Peddock Capital Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-172
Closed -$30K 229
2020
Q4
$30K Buy
+172
New +$29.7K 0.02% 194
2020
Q1
Sell
-172
Closed -$25K 178
2019
Q4
$25K Buy
+172
New +$24.8K 0.01% 191
2019
Q2
Sell
-172
Closed -$23K 176
2019
Q1
$23K Hold
172
0.01% 193
2018
Q4
$19K Hold
172
0.01% 201
2018
Q3
$26K Hold
172
0.01% 199
2018
Q2
$27K Hold
172
0.01% 197
2018
Q1
$24K Hold
172
0.01% 197
2017
Q4
$24K Hold
172
0.01% 199
2017
Q3
$22K Hold
172
0.01% 197
2017
Q2
$23K Hold
172
0.01% 200
2017
Q1
$21K Hold
172
0.01% 181
2016
Q4
$19K Hold
172
0.01% 176
2016
Q3
$20K Buy
+172
New +$20.3K 0.01% 189
2014
Q1
Sell
-6,650
Closed -$522K 91
2013
Q4
$522K Buy
+6,650
New +$567K 0.41% 49

Other funds holding LH

Peddock Capital Advisors's LH Position: Q1 2021 in Review

Peddock Capital Advisors sold out of Labcorp (LH) in Q1 2021, closing a stake of 172 shares — an estimated $30K sold.

Peddock Capital Advisors first reported a position in LH in Q4 2013 and held it in 14 quarters. The position peaked at $522K in Q4 2013. 920 funds tracked by Wall St. Rank hold LH as of Q1 2021.

  • Peddock Capital Advisors reported no remaining Labcorp position as of Q1 2021 after selling out during the quarter.
  • Peddock Capital Advisors sold 172 Labcorp shares in Q1 2021, an estimated $30K.
  • Peddock Capital Advisors first reported a position in Labcorp in Q4 2013 and held it in 14 quarters.
  • Peddock Capital Advisors's Labcorp position peaked at $522K in Q4 2013.
  • 920 funds tracked by Wall St. Rank held Labcorp as of Q1 2021.

Based on Peddock Capital Advisors's 13F filing for Q1 2021, filed 17 May 2021.